Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target
Source abstract
Abstract
Biomaterial-induced tissue responses in patients with total joint replacement are associated with the generation of wear particles, which may lead to chronic inflammation and local bone destruction (periprosthetic osteolysis). Inflammatory reactions associated with wear particles are mediated by several important signaling pathways, the most important of which involves the transcription factor NF-κB. NF-κB activation is essential for macrophage recruitment and maturation, as well as the production of pro-inflammatory cytokines and chemokines such as TNF-α, IL-1β, IL-6 and MCP1. In addition, NF-κB activation contributes to osteoclast differentiation and maturation via RANK/RANKL signaling, which increases bone destruction and reduces bone formation. Targeting individual downstream cytokines directly (such as TNF-α or IL-1β) may not effectively prevent wear particle induced osteolysis. A more logical upstream therapeutic approach may be provided by direct modulation of the core IκB/IKKα/β/NF-κB signaling pathway in the local environment. However, the timing, dose and strategy for administration should be considered. Suppression of chronic inflammation via inhibition of NF-κB activity in patients with malfunctioning joint replacements may be an effective strategy to mitigate wear particle induced periprosthetic osteolysis.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Orthopaedic implants and arthroplasty · Orthopedic Infections and Treatments · Bone and Joint Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Implant wear symposium clinical work G. What patient and surgical factors contribute to implant wear and osteolysis in total joint arthroplasty?
2. The central role of wear debris in periprosthetic osteolysis10.1007/s11420-006-9003-6 ↗
3. Titanium alloys in total joint replacement – a materials science perspective10.1016/S0142-9612(97)00146-4 ↗
4. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
5. Correlating macrophage morphology and cytokine production resulting from biomaterial contact10.1002/jbm.a.34309 ↗
6. Biomaterials in orthopaedics10.1098/rsif.2008.0151 ↗
7. Adaptive immune responses to biomaterials
8. Relationship of acetabular wear to osteolysis and loosening in total hip arthroplasty
9. Migration and wear of long-term successful Charnley total hip replacements10.1302/0301-620X.80B3.8455 ↗
10. The seven-year wear of highly cross-linked polyethylene in total hip arthroplasty: a double-blind, randomized controlled trial using radiostereometric analysis10.2106/JBJS.J.00287 ↗
11. A prospective, randomized study of cross-linked and non-cross-linked polyethylene for total hip arthroplasty at 10-year follow-up10.1016/j.arth.2012.03.048 ↗
12. Wear analysis of first-generation highly cross-linked polyethylene in primary total hip arthroplasty: an average 9-year follow-up10.1016/j.arth.2012.01.006 ↗
13. Wear particulate and osteolysis10.1016/j.ocl.2004.06.015 ↗
14. Metal-on-metal total hip arthroplasty: the concerns10.1097/01.blo.0000150309.48474.8b ↗
15. Joon · 2002
16. Alternative bearing surfaces for total joint arthroplasty10.5435/00124635-199807000-00001 ↗
17. Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins10.1172/JCI112869 ↗
18. Current concepts: immunology. Neutrophils in human diseases10.1056/NEJM198709103171107 ↗
19. Mechanisms of inflammation and infection with implanted devices
20. Granulomatous inflammation – a review10.1136/jcp.36.7.723 ↗
21. Current concepts: immunology. Monocytes and macrophages10.1056/NEJM198803243181205 ↗
22. The hemostatic system as a regulator of angiogenesis10.1074/jbc.275.3.1521 ↗
23. Immune responses to implants – a review of the implications for the design of immunomodulatory biomaterials10.1016/j.biomaterials.2011.05.078 ↗
24. Mechanisms of inflammation and infection with implanted devices10.1016/1054-8807(93)90045-4 ↗
25. Cellular and molecular dynamics in the foreign body reaction10.1089/ten.2006.12.1955 ↗
26. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes10.1016/j.biomaterials.2004.01.023 ↗
27. Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies10.1016/j.addr.2011.06.012 ↗
28. The role of complement in biomaterial-induced inflammation10.1016/j.molimm.2006.06.020 ↗
29. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface10.1016/j.biomaterials.2004.05.011 ↗
30. Mast cells mediate acute inflammatory responses to implanted biomaterials10.1073/pnas.95.15.8841 ↗
31. Histamine release and fibrinogen adsorption mediate acute inflammatory responses to biomaterial implants in humans10.1186/1479-5876-5-31 ↗
32. Protein adsorption and cell attachment to patterned surfaces10.1002/(SICI)1097-4636(200002)49:2<200::AID-JBM7>3.0.CO;2-L ↗
33. Effects of adsorbed heat labile serum proteins and fibrinogen on adhesion and apoptosis of monocytes/macrophages on biomaterials10.1023/A:1024951330265 ↗
34. Role of plasma fibronectin in the foreign body response to biomaterials10.1016/j.biomaterials.2007.04.035 ↗
35. Vitronectin is a critical protein adhesion substrate for IL-4-induced foreign body giant cell formation10.1002/jbm.a.31658 ↗
36. Mediation of biomaterial–cell interactions by adsorbed proteins: a review10.1089/ten.2005.11.1 ↗
37. The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles10.4049/jimmunol.107.6.1535 ↗
38. The immunologic release of constituents from neutrophil leukocytes. II. Mechanisms of release during phagocytosis, and adherence to nonphagocytosable surfaces10.4049/jimmunol.107.6.1547 ↗
39. The influence of plasma proteins and platelets on oxygen radical production and F-actin distribution in neutrophils adhering to polymer surfaces10.1016/S0142-9612(01)00305-2 ↗
40. Oxygen radical production in neutrophils interacting with platelets and surface-immobilized plasma proteins: role of tyrosine phosphorylation10.1002/jbm.a.10081 ↗
41. INOS-mediated generation of reactive oxygen and nitrogen species by biomaterial-adherent neutrophils10.1002/jbm.a.30907 ↗
42. Biomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitro10.1006/cyto.2002.1048 ↗
43. Differential response to chemically altered polyethylene by activated mature human monocyte-derived macrophages10.1016/S0142-9612(02)00088-1 ↗
44. In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry10.1002/jbm.a.10425 ↗
45. Macrophage behavior on surface-modified polyurethanes10.1163/156856204323046843 ↗
46. Effect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines10.1002/jbm.a.30075 ↗
47. Characterization of topographical effects on macrophage behavior in a foreign body response model10.1016/j.biomaterials.2010.01.074 ↗
48. Macrophages – key cells in the response to wear debris from joint replacements10.1002/jbm.a.34599 ↗
49. The response of macrophages to titanium particles is determined by macrophage polarization10.1016/j.actbio.2013.06.027 ↗
50. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen10.1016/j.biomaterials.2004.08.023 ↗
51. Altered adherent leukocyte profile on biomaterials in Toll-like receptor 4 deficient mice10.1016/j.biomaterials.2009.09.077 ↗
52. Protease expression in interface tissues around loose arthroplasties10.1097/01.blo.0000136650.33036.fd ↗
53. Does endotoxin contribute to aseptic loosening of orthopedic implants?10.1002/jbm.b.30150 ↗
54. Lipopolysaccharide found in aseptic loosening of patients with inflammatory arthritis10.1097/01.blo.0000224050.94248.38 ↗
55. Accumulation of LPS by polyethylene particles decreases bone attachment to implants10.1002/jor.20038 ↗
56. The balance between endotoxin accumulation and clearance during particle-induced osteolysis in murine calvaria10.1002/jor.20289 ↗
57. Immunogenecity of modified alkane polymers is mediated through TLR1/2 activation10.1371/journal.pone.0002438 ↗
58. Metal-on-metal hips: cobalt can induce an endotoxin-like response10.1136/annrheumdis-2012-202468 ↗
59. Adverse reactions to metal-on-metal implants10.1038/nrrheum.2012.218 ↗
60. Toll-like receptor 4 signaling pathway mediates proinflammatory immune response to cobalt-alloy particles10.1016/j.cellimm.2013.04.003 ↗
61. Endosomal damage and TLR2 mediated inflammasome activation by alkane particles in the generation of aseptic osteolysis10.1016/j.molimm.2009.09.023 ↗
62. Orthopedic wear debris mediated inflammatory osteolysis is mediated in part by NALP3 inflammasome activation10.1002/jor.22190 ↗
63. Involvement of toll-like receptor 4 in the inflammatory reaction induced by hydroxyapatite particles10.1016/j.biomaterials.2006.09.015 ↗
64. Bacterial pathogen-associated molecular patterns stimulate biological activity of orthopaedic wear particles by activating cognate toll-like receptors10.1074/jbc.M110.136895 ↗
65. Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles10.1016/j.biomaterials.2011.04.046 ↗
66. Macrophages in degradation of collagen hydroxylapatite(CHA), beta-tricalcium phosphate ceramics (TCP) artificial bone-graft an in-vivo study
67. Oxidative mechanisms of poly(carbonate urethane) and poly(ether urethane) biodegradation: in vivo and in vitro correlations10.1002/jbm.a.30067 ↗
68. Particle disease: biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty10.1177/1753425912451779 ↗
69. The basic science of periprosthetic osteolysis
70. Does endotoxin contribute to aseptic loosening of orthopedic implants?10.1002/jbm.b.30150 ↗
71. The biology of aseptic osteolysis10.1097/BLO.0b013e31804b4147 ↗
72. The cellular and molecular biology of periprosthetic osteolysis10.1097/01.blo.0000238813.95035.1b ↗
73. Aseptic loosening, not only a question of wear: a review of different theories10.1080/17453670610045902 ↗
74. Function and activation of NF-kappa B in the immune system10.1146/annurev.iy.12.040194.001041 ↗
75. NF-kappa B: a lesson in family values10.1016/0092-8674(95)90506-5 ↗
76. The NF-kappa B and I kappa B proteins: new discoveries and insights10.1146/annurev.immunol.14.1.649 ↗
77. Upstream signal transduction of NF-kB activation
78. Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro10.2106/00004623-199905000-00002 ↗
79. Induction of interleukin-6 release in human osteoblast-like cells exposed to titanium particles in vitro10.1007/s00223001125 ↗
80. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis10.1002/jor.1100180321 ↗
81. The effect of particle wear debris on NFkappaB activation and pro-inflammatory cytokine release in differentiated THP-1 cells10.1002/jbm.1264 ↗
82. The role of p105 protein in NFkappaB activation in ANA-1 murine macrophages following stimulation with titanium particles10.1016/S0736-0266(01)00180-2 ↗
83. Activation of NF-kappaB signalling and TNFalpha-expression in THP-1 macrophages by TiAlV- and polyethylene-wear particles
84. Toll-like receptors in the interface membrane around loosening total hip replacement implants10.1002/jbm.a.31235 ↗
85. Titanium particles modulate expression of Toll-like receptor proteins10.1002/jbm.a.32495 ↗
86. Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles10.1002/jor.21369 ↗
87. Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles10.1016/j.biomaterials.2011.04.046 ↗
88. Endosomal damage and TLR2 mediated inflammasome activation by alkane particles in the generation of aseptic osteolysis10.1016/j.molimm.2009.09.023 ↗
89. Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies10.2106/00004623-199072020-00014 ↗
90. A histologic and biochemical comparison of the interface tissues in cementless and cemented hip prostheses
91. Extracellular matrix metalloproteinases around loose total hip prostheses10.3109/17453679408995454 ↗
92. Tissue inhibitor of metalloproteinase 1, collagenolytic and gelatinolytic activity in loose hip endoprostheses
93. High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints
94. Acid attack and cathepsin K in bone resorption around total hip replacement prosthesis10.1359/jbmr.2001.16.10.1780 ↗
95. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases10.1001/jama.292.4.490 ↗
96. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation10.1016/S0092-8674(00)81569-X ↗
97. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis10.1038/16852 ↗
98. Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand10.1359/jbmr.2000.15.11.2178 ↗
99. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB. RANK ligand and osteoprotegerin10.1016/S0142-9612(03)00556-8 ↗
100. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation10.1016/S0002-9440(10)64942-5 ↗